The batch-specific Certificate of Analysis (COA) details peptide identity, net peptide content, format (e.g., lyophilized state), and any relevant excipient or counterion information, supporting method-level reproducibility, experimental standardization, and documentation control in research environments
Simply re-select the syringe size to correct it
The rationale: BPC-157 promotes angiogenesis and growth factor modulation while TB-500 drives actin remodeling and cell migration complementary mechanisms for tissue repair
The absence of reported adverse effects in short-duration animal studies is not equivalent to confirmed long-term safety
Engineered for continuous, direct-to-bloodstream delivery, this patch provides effective doses of both NAD+ and BPC-157, supporting sustained energy, cellular repair, and tissue recovery in one convenient, non-invasive solution
**Patient-Centric Approach** We prioritize a patient-centric approach, ensuring that you are informed and empowered throughout your journey with BPC-157 therapy